The Drug Abuse Screening Test (DAST-10) is a validated 10-item self-report questionnaire developed by Harvey A. Skinner, Ph.D. in 1982 to screen for drug use problems (excluding alcohol and tobacco) over the past 12 months. Each yes/no item is scored 0 or 1, yielding a total score of 0–10, with a clinical cutoff of 3 indicating moderate-level drug involvement (Skinner, 1982). The DAST-10 demonstrates excellent internal consistency (Cronbach's α = 0.86–0.94) and strong sensitivity (0.98) and specificity (0.91) across diverse populations. Zentake's digital DAST-10 delivers the questionnaire via a HIPAA-compliant intake form and auto-calculates severity levels upon submission.
Each of the 10 items is answered Yes or No. Items 1, 2, and 4–10 each score 1 point for a "Yes" response; item 3 scores 1 point for a "No" response. Total scores range from 0 to 10. Clinical interpretation ranges are:
Zentake automatically calculates the DAST-10 total score and severity category upon form submission, eliminating manual scoring errors and enabling immediate clinical triage decisions.
Step 1: Introduce the questionnaire. Explain to the patient that the DAST-10 is a confidential screening tool asking about drug use (excluding alcohol and tobacco) in the past 12 months. Zentake's digital intake platform delivers the form automatically upon patient check-in, reducing clinician administrative burden.
Step 2: Patient self-completes the 10-item questionnaire. The DAST-10 is designed for self-administration and typically takes under 2 minutes. Patients can complete it securely via Zentake's mobile-friendly digital form on any device.
Step 3: Review the auto-calculated score. Zentake instantly calculates the total score and flags the severity level (None/Low/Moderate/Substantial/Severe) in the clinician dashboard, allowing for rapid review before the patient encounter.
Step 4: Conduct a clinical follow-up. For scores of 3 or higher, conduct a brief clinical interview to explore drug use patterns, frequency, and impact on functioning. Document your findings directly in the EMR via Zentake's integration.
Step 5: Establish a monitoring plan. For lower-scoring patients, schedule a reassessment at the next visit. Zentake's longitudinal tracking enables side-by-side score comparisons over time, supporting treatment planning and monitoring recovery progress.
Scoring: Paper DAST-10 requires manual item-level calculation with awareness of the reverse-scored item 3; Zentake auto-calculates the total and severity category instantly with zero clinician effort.
Completion: Paper forms can be lost, illegible, or returned incomplete; Zentake's digital form requires completion of all items before submission, ensuring complete data.
Delivery: Paper requires printing, distributing, and collecting physical forms; Zentake sends the DAST-10 via secure link by text or email before the patient arrives.
Data Storage: Paper forms must be scanned and manually filed; Zentake stores all responses securely in the cloud with automatic audit trails meeting HIPAA requirements.
Longitudinal Tracking: Manually comparing paper scores across visits is time-consuming; Zentake's measures dashboard plots DAST-10 scores across encounters for instant trend visualization.
Security: Paper forms risk being seen or misplaced; Zentake uses 256-bit encryption and role-based access controls to protect sensitive substance use data.
Integration: Paper data must be manually entered into the EMR; Zentake integrates with leading EMR platforms to push completed DAST-10 data directly to the patient chart.
Cost: Paper forms incur printing, staff time, and storage costs; Zentake replaces these with a scalable digital workflow that saves administrative overhead.
What does the DAST-10 measure?
The DAST-10 measures the degree of problems associated with drug misuse (excluding alcohol and tobacco) over the past 12 months. It does not identify specific substances used but quantifies the overall level of drug involvement and associated consequences, producing a score from 0 to 10 that corresponds to severity levels from no problem to severe.
How do you score the DAST-10?
Sum the yes responses for items 1, 2, and 4–10, and add 1 point for a no response on item 3. Scores of 0 = no problem, 1–2 = low, 3–5 = moderate, 6–8 = substantial, and 9–10 = severe drug involvement. Zentake calculates this automatically with built-in form logic upon submission.
How long does the DAST-10 take to complete?
The DAST-10 is designed for rapid self-administration and typically takes less than 2 minutes. Its brevity makes it ideal for routine clinical screening without disrupting appointment flow.
Is the DAST-10 free to use?
The DAST-10 was developed as a public domain clinical tool and is freely available. Zentake's digital DAST-10 template is included in all Zentake plans, with no additional per-assessment licensing fees.
What population is the DAST-10 validated for?
The DAST-10 is validated for use with adults (18 and older) across a wide range of clinical and community settings, including addiction treatment centers, primary care, emergency departments, and correctional facilities. A separate adolescent version (DAST-A) is available for younger populations.
Who should administer the DAST-10?
The DAST-10 is designed for self-administration by the patient but is appropriate for use in any clinical setting where a trained clinician can follow up on positive screens. It is routinely administered by physicians, nurses, social workers, behavioral health specialists, and addiction counselors.
What should clinicians do with a DAST-10 score of 3 or higher?
A score of 3–5 indicates moderate drug involvement and warrants a more detailed clinical interview and brief motivational intervention. Scores of 6 or higher indicate substantial or severe involvement requiring intensive assessment, specialty referral, or treatment initiation. Clinicians should use professional judgment and pair scores with clinical history and patient context.
Can the DAST-10 screen for alcohol use?
No. The DAST-10 is specifically designed to screen for drug use problems excluding alcohol and tobacco. For alcohol screening, the AUDIT or AUDIT-C should be used alongside the DAST-10 for a comprehensive substance use evaluation.
1. Skinner HA. The Drug Abuse Screening Test. Addictive Behaviors. 1982;7(4):363–371.
2. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal of Substance Abuse Treatment. 2007;32(2):189–198.
3. McNeely J, et al. The Psychometric Properties of the Drug Abuse Screening Test (DAST-10) in Primary Care. Drug and Alcohol Dependence. 2020;214:108169.
Last updated: March 2026
The leading patient intake platform. HIPAA compliant forms for healthcare providers and organizations. Find out what you're missing!
